{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:02:45Z","timestamp":1785294165689,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jchromb.2023.123979","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T12:09:25Z","timestamp":1703678965000},"page":"123979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Simultaneous determination of oxacillin and cloxacillin in plasma and CSF using turbulent flow liquid chromatography coupled to high-resolution mass spectrometry: Application in therapeutic drug monitoring"],"prefix":"10.1016","volume":"1233","author":[{"given":"Sarra","family":"Mahfoudhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Mory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Le Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Coudore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najoua","family":"El Helali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fethi","family":"Safta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Le Monnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2023.123979_b0005","doi-asserted-by":"crossref","unstructured":"G.G. Dumancas, R.S. Hikkaduwa Koralege, E.R. Mojica, B.S. Murdianti, P.J. Pham, Penicillins, in: P. Wexler, directeurs. Encyclopedia of toxicology, 3rd ed. Academic Press, Oxford, 2014, pp. 768\u2013772.","DOI":"10.1016\/B978-0-12-386454-3.00764-8"},{"issue":"10","key":"10.1016\/j.jchromb.2023.123979_b0010","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0399-077X(05)80580-3","article-title":"Activit\u00e9 in vitro de la cloxacilline sur les staphylocoques, les streptocoques du groupe A et Clostridium perfringens. Index Inhibiteurs S\u00e9riques","volume":"24","author":"Reverdy","year":"1994","journal-title":"Med Mal Infect."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123979_b0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cpt19645126","article-title":"Cloxacillin, a new oral synthetic penicillin: Comparisons with oxacillin","volume":"5","author":"Sidell","year":"1964","journal-title":"Clin Pharmacol Ther."},{"issue":"3","key":"10.1016\/j.jchromb.2023.123979_b0020","first-page":"129","article-title":"B\u00eatalactamines","volume":"1","author":"Cavallo","year":"2004","journal-title":"EMC - Mal Infect."},{"key":"10.1016\/j.jchromb.2023.123979_b0025","series-title":"Kucers\u2019 The Use of Antibiotics","author":"Grayson","year":"2010"},{"issue":"9","key":"10.1016\/j.jchromb.2023.123979_b0030","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1248\/cpb.31.3292","article-title":"Comparative pharmacokinetics of metabolism and urinary excretion of isoxazolylpenicillins in man","volume":"31","author":"Murai","year":"1983","journal-title":"Chem Pharm Bull."},{"issue":"11","key":"10.1016\/j.jchromb.2023.123979_b0035","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1248\/cpb.29.3290","article-title":"High performance liquid chromatographic analysis and pharmacokinetic investigation of oxacillin and its metabolites in man","volume":"29","author":"Murai","year":"1981","journal-title":"Chem Pharm Bull."},{"issue":"3","key":"10.1016\/j.jchromb.2023.123979_b0040","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0378-4347(00)81714-4","article-title":"Analysis of isoxazolyl penicillins and their metabolites in body fluids by highperformance liquid chromatography","volume":"183","author":"Thijssen","year":"1980","journal-title":"J Chromatogr B Biomed Sci App."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123979_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","article-title":"Augmented renal clearance: implications for antibacterial dosing in the critically ill","volume":"49","author":"Udy","year":"2010","journal-title":"Clin Pharmacokinet."},{"issue":"8","key":"10.1016\/j.jchromb.2023.123979_b0050","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1128\/AAC.00176-16","article-title":"Simultaneous determination of eight \u03b2-lactam antibiotics, amoxicillin, cefazolin, cefepime, cefotaxime, ceftazidime, cloxacillin, oxacillin, and piperacillin, in human plasma by using ultra-high-performance liquid chromatography with ultraviolet detection","volume":"60","author":"Legrand","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"10.1016\/j.jchromb.2023.123979_b0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijantimicag.2015.06.016","article-title":"Assays for therapeutic drug monitoring of \u03b2-lactam antibiotics: A structured review","volume":"46","author":"Carlier","year":"2015","journal-title":"Int J Antimicrob Agents."},{"issue":"5","key":"10.1016\/j.jchromb.2023.123979_b0060","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/jac\/dkt523","article-title":"An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units","volume":"69","author":"Wong","year":"2014","journal-title":"J Antimicrob Chemother."},{"issue":"10","key":"10.1016\/j.jchromb.2023.123979_b0065","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1128\/AAC.00533-11","article-title":"Simultaneous determination of 12 \u03b2-Lactam antibiotics in human plasma by high-performance liquid chromatography with UV Detection: Application to therapeutic drug monitoring","volume":"55","author":"Verdier","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"issue":"10","key":"10.1016\/j.jchromb.2023.123979_b0070","doi-asserted-by":"crossref","first-page":"1415.e1","DOI":"10.1016\/j.cmi.2020.04.046","article-title":"Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningitis","volume":"26","author":"Le Turnier","year":"2020","journal-title":"Clin Microbiol Infect."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123979_b0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13613-017-0255-8","article-title":"Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects","volume":"7","author":"Neuville","year":"2017","journal-title":"Ann Intensive Care."},{"key":"10.1016\/j.jchromb.2023.123979_b0080","unstructured":"European Medicines Agency. Guideline on bioanalytical method validation (EMEA\/CHMP\/EWP\/192217\/2009). Amsterdam: EMA; 2011."},{"key":"10.1016\/j.jchromb.2023.123979_b0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2017.09.014","article-title":"A simple ultra-high-performance liquid chromatography-high resolution mass spectrometry assay for the simultaneous quantification of 15 antibiotics in plasma","volume":"1065\u20131066","author":"Lefeuvre","year":"2017","journal-title":"J Chromatogr B."},{"key":"10.1016\/j.jchromb.2023.123979_b0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cca.2017.03.009","article-title":"Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of \u03b2-lactam antibiotic concentration in human plasma","volume":"468","author":"Rigo-Bonnin","year":"2017","journal-title":"Clin Chim Acta."},{"issue":"8","key":"10.1016\/j.jchromb.2023.123979_b0095","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/bmc.3125","article-title":"Development and validation of a liquid chromatography\/tandem mass spectrometry method for the quantification of flucloxacillin and cloxacillin in microdialysis samples: Quantification of flucloxacillin and cloxacillin in microdialysate","volume":"28","author":"Larmen\u00e9-Beld","year":"2014","journal-title":"Biomed Chromatogr."},{"issue":"8","key":"10.1016\/j.jchromb.2023.123979_b0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00228-014-1695-9","article-title":"Cloxacillin concentrations in serum, subcutaneous fat, and muscle in patients with chronic critical limb ischemia","volume":"70","author":"Jonsson","year":"2014","journal-title":"Eur J Clin Pharmacol."},{"issue":"2","key":"10.1016\/j.jchromb.2023.123979_b0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2710.1988.tb00164.x","article-title":"Simultaneous high-pressure liquid chromatographic analysis of ampicillin and cloxacillin in serum and urine","volume":"13","author":"Abuirjeie","year":"1988","journal-title":"J Clin Pharm Ther."},{"key":"10.1016\/j.jchromb.2023.123979_b0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.56808\/3027-7922.3315","article-title":"Simultaneous estimation of cefixime and cloxacillin in human plasma by reversed phase-HPLC with UV detection","volume":"36","author":"Bhinge","year":"2012","journal-title":"Thai J Pharm Sci."},{"key":"10.1016\/j.jchromb.2023.123979_b0115","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints. Clinical breakpoints - breakpoints and guidance."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123979_b0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","article-title":"Optimization of the treatment with beta-lactam antibiotics in critically ill patients\u2014guidelines from the French Society of Pharmacology and Therapeutics and the French Society of Anaesthesia and Intensive Care Medicine","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223003896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223003896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:12:15Z","timestamp":1761606735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023223003896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":24,"alternative-id":["S1570023223003896"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123979","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous determination of oxacillin and cloxacillin in plasma and CSF using turbulent flow liquid chromatography coupled to high-resolution mass spectrometry: Application in therapeutic drug monitoring","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123979"}}